Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.

Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, Kim WR, Gores GJ, Roberts RO, Olson JE, Therneau TM, Roberts LR.

Hepatology. 2013 Feb;57(2):648-55. doi: 10.1002/hep.26092. Epub 2012 Dec 12.

2.

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.

Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM.

Am J Gastroenterol. 2007 May;102(5):1016-21. Epub 2007 Feb 23.

PMID:
17324130
3.

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.

Tao LY, He XD, Qu Q, Cai L, Liu W, Zhou L, Zhang SM.

Liver Int. 2010 Feb;30(2):215-21. doi: 10.1111/j.1478-3231.2009.02149.x. Epub 2009 Oct 14.

PMID:
19840244
4.

Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study.

Liu ZY, Zhou YM, Shi LH, Yin ZF.

Hepatobiliary Pancreat Dis Int. 2011 Dec;10(6):626-31.

5.

Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.

Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, Olsen JH, McGlynn KA.

Int J Cancer. 2007 Feb 1;120(3):638-41.

6.

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.

Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA.

Hepatology. 2011 Aug;54(2):463-71. doi: 10.1002/hep.24397. Epub 2011 Jun 30.

7.

Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy.

Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, Martelli C, Savio A, Trevisi P, Nardi G.

Cancer Causes Control. 2001 Dec;12(10):959-64.

PMID:
11808716
8.

Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.

Jing W, Jin G, Zhou X, Zhou Y, Zhang Y, Shao C, Liu R, Hu X.

Eur J Cancer Prev. 2012 Jan;21(1):24-31. doi: 10.1097/CEJ.0b013e3283481d89.

PMID:
21857525
9.

Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.

Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, Lee SK, Seo DW, Kim MH, Suh DJ.

Am J Gastroenterol. 2008 Jul;103(7):1716-20. doi: 10.1111/j.1572-0241.2008.01796.x. Epub 2008 Jun 28.

PMID:
18557716
10.

Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma.

Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T.

Cancer Sci. 2004 Jul;95(7):592-5.

11.

Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom.

Burr NE, Talboys RJ, Savva S, Clark A, Phillips M, Metcalfe M, Dennison A, Robinson R, Lewis MP, Rhodes M, Rushbrook S, Hart AR.

Dig Dis Sci. 2014 Jul;59(7):1567-72. doi: 10.1007/s10620-014-3056-z. Epub 2014 Feb 18.

PMID:
24535250
12.

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.

Donadon V, Balbi M, Mas MD, Casarin P, Zanette G.

Liver Int. 2010 May;30(5):750-8. doi: 10.1111/j.1478-3231.2010.02223.x. Epub 2010 Mar 12.

PMID:
20331505
13.

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8. Epub 2007 Aug 6.

14.

The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China.

Wu Q, He XD, Yu L, Liu W, Tao LY.

Asian Pac J Cancer Prev. 2012;13(5):1963-9.

15.

Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.

Lee BS, Park EC, Park SW, Nam CM, Roh J.

World J Gastroenterol. 2015 Jan 14;21(2):502-10. doi: 10.3748/wjg.v21.i2.502.

16.

Analyzing risk factors for intrahepatic cholangiocarcinoma.

Fujita T.

Hepatology. 2013 Nov;58(5):1862-3. doi: 10.1002/hep.26448. Epub 2013 Sep 24. No abstract available.

PMID:
23609480
17.

[Case-control study of risk factors in cholangiocarcinoma].

Tao LY, He XD, Cai L, Liu W, Ji WJ, Zhao L, Zhang SM.

Zhonghua Zhong Liu Za Zhi. 2009 Oct;31(10):759-63. Chinese.

PMID:
20021829
18.

Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma.

Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY.

Br J Cancer. 2009 Jun 2;100(11):1765-70. doi: 10.1038/sj.bjc.6605063. Epub 2009 May 12.

19.

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.

Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA.

Gastroenterology. 2005 Mar;128(3):620-6.

PMID:
15765398
20.

[Risk factors of intrahepatic cholangiocarcinoma: a case-control study].

Zhou HB, Xu QR, Wang H, Zhou DX, Wang H, Wang Q, Zhou SS, Tu QQ, Sun ZQ, Ai L, Wu MC, Hu HP.

Zhonghua Gan Zang Bing Za Zhi. 2009 Dec;17(12):935-9. Chinese.

PMID:
20038337
Items per page

Supplemental Content

Write to the Help Desk